1. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. Issue 5 (October 2015) Authors: Duffy, AG; Ulahannan, SV; Cao, L; Rahma, OE; Makarova-Rusher, OV; Kleiner, DE; Fioravanti, S; Walker, M; Carey, S; Yu, Y; Venkatesan, AM; Turkbey, B; Choyke, P; Trepel, J; Bollen, KC; Steinberg, SM; Figg, WD; Greten, TF Journal: United European Gastroenterology journal Issue: Volume 3:Issue 5(2015:Oct.) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. Issue 5 (1st October 2015) Authors: Duffy, AG; Ulahannan, SV; Cao, L; Rahma, OE; Makarova-Rusher, OV; Kleiner, DE; Fioravanti, S; Walker, M; Carey, S; Yu, Y; Venkatesan, AM; Turkbey, B; Choyke, P; Trepel, J; Bollen, KC; Steinberg, SM; Figg, WD; Greten, TF Journal: United European Gastroenterology journal Issue: Volume 3:Issue 5(2015:Oct.) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗